Stock Taper Revenue: $87.3 million, down 4.5% year-over-year, primarily due to a $2.7 million tariff refund.
Gross Profit: $25.8 million with a gross margin of 29.5%, down from 34.7% in Q2 2025, attributed to higher raw material costs and lower production utilization.
Operating Expenses: Increased to $27.5 million, a 16.1% rise year-over-year, driven by higher legal and professional service fees.
Net Loss: GAAP net loss of $12 million; adjusted net loss of $5.3 million compared to an adjusted net profit of $16.3 million in Q2 2025.
Adjusted EBITDA: $3.6 million, down from $25.9 million in Q2 2025.
Six-Month Performance: Revenue decreased by 28.8% to $147.5 million; adjusted net loss of $19.9 million compared to a profit of $35.6 million in the prior year.
Huzhou Phase 3.2 Expansion: Production capacity ramp-up expected to add 2 GWh annually, with commissioning completed.
R&D Milestones: Development of a new solid-state battery architecture showing promising durability and thermal stability, aimed at robotics applications.
Market Focus: Continued emphasis on high barrier industries and transit markets, with a strategic push towards profitability and margin discipline.
Production Goals: Anticipated start of serial production in 2026 at the Huzhou facility; pipeline assembly in Clarksville, Tennessee on schedule for initial output by year-end.
Strategic Priorities: Focus on operational execution, protecting gross margins, and deploying innovations like the KAF electric powertrain.
Revenue Decline: Significant year-over-year revenue drop, influenced by tariff refunds and reduced sales volumes.
Increased Operating Expenses: Rising costs in G&A, R&D, and marketing, particularly due to legal fees and customer retention initiatives.
Cash Flow Issues: Net cash used in operating activities was $33.3 million, a stark decline from $44.3 million generated in the same period last year.
APAC Market Challenges: Sales in the APAC region fell 23% in Q2, with a 45% decline year-to-date, attributed to regulatory changes and demand shifts.
No specific Q&A highlights were provided in the transcript, but management emphasized their commitment to navigating macroeconomic challenges and executing strategic milestones to enhance shareholder value. Overall, Microvast is facing significant challenges in revenue and profitability while making strides in production capacity and R&D. The company is focused on operational improvements and strategic market expansions, but must address rising costs and declining sales in key regions.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT